Kai-Yang Wang

Kai-Yang Wang

Auto-generated profile, based on publicly available information

Kai-Yang Wang

Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
KWKai-Yang Wang
Kai-Yang Wang
XJXiang-Yun Jin
Xiang-Yun Jin
YMYu-Hui Ma
Yu-Hui Ma
WCWeijie Cai
Weijie Cai
WXWei-Yuan Xiao
Wei-Yuan Xiao
JDJian Ding
Jian Ding
Background: Cartilage injury and pathological degeneration are reported in millions of patients globally. Cartilages such as articular hyaline cartilage are characterized by poor self-regeneration ability due to lack of vascular tissue. Current treatment methods adopt foreign cartilage analogue implants or microfracture surgery to accelerate tissue repair and regeneration. These methods are invasive and are associated with the formation of fibrocartilage, which warrants further exploration of new cartilage repair materials. The present study aims to develop an injectable modified gelatin hydrogel. Method: The hydrogel effectively adsorbed proteoglycans secreted by chondrocytes adjacent to the cartilage tissue in situ, and rapidly formed suitable chondrocyte survival microenvironment modified by ε-poly-L-lysine (EPL). Besides, dynamic covalent bonds were introduced between glucose and phenylboronic acids (PBA). These bonds formed reversible covalent interactions between the cis−diol groups on polyols and the ionic boronate state of PBA. PBA-modified hydrogel induced significant stress relaxation, which improved chondrocyte viability and cartilage differentiation of stem cells. Further, we explored the ability of these hydrogels to promote chondrocyte viability and cartilage differentiation of stem cells through chemical and mechanical modifications. Results: In vivo and in vitro results demonstrated that the hydrogels exhibited efficient biocompatibility. EPL and PBA modified GelMA hydrogel (Gel-EPL/B) showed stronger activity on chondrocytes compared to the GelMA control group. The Gel-EPL/B group induced the secretion of more extracellular matrix and improved the chondrogenic differentiation potential of stem cells. Finally, thus hydrogel promoted the tissue repair of cartilage defects. Conclusion: Modified hydrogel is effective in cartilage tissue repair.

1 June 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
YSYi-Fan Shen
Yi-Fan Shen
JHJing-Huan Huang
Jing-Huan Huang
ZWZe-En Wu
Ze-En Wu
KWKai-Yang Wang
Kai-Yang Wang
JZJin Zheng
Jin Zheng
JLJingfeng Li
Jingfeng Li

1 November 2021 in Injury
Verified
Journal Article
Closed access
KWKaiyang Wang
Kaiyang Wang
MNMing Ni
Ming Ni
PLPeng Liao
Peng Liao
BDBang Dou
Bang Dou
XYXu Yan
Xu Yan
JMJiong Mei
Jiong Mei

9 March 2020 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
YSYi-Fan Shen
Yi-Fan Shen
JHJing-Huan Huang
Jing-Huan Huang
KWKai-Yang Wang
Kai-Yang Wang
JZJin Zheng
Jin Zheng
LCLin Cai
Lin Cai
JLJingfeng Li
Jingfeng Li
Background: Diabetic wounds are a disturbing and rapidly growing clinical problem. A novel peptide, parathyroid hormone related peptide (PTHrP-2), is assumed as multifunctional factor in angiogenesis, fibrogenesis and re-epithelization. This study aims to test PTHrP-2 efficiency and mechanism in wound healing.Methods: Through repair phenomenon in vivo some problems were detected, and further research on their mechanisms was made. In vivo therapeutic effects of PTHrP-2 were determined by HE, Masson, microfil and immunohistochemical staining. In vitro direct effects of PTHrP-2 were determined by proliferation, migration, Vascular Endothelial Grown Factor and collagen I secretion of cells and Akt/ Erk1/2 pathway change. In vitro indirect effects of PTHrP-2 was study via exosomes. Exosomes from PTHrP-2 untreated and treated HUVECs and HFF-1 cells were insolated and identified. Exosomes were co-cultured with original cells, HUVECs or HFF-1 cells, and epithelial cells. Proliferation and migration and pathway change were observed. PTHrP-2-HUVEC-Exos were added into in vivo wound to testify its hub role in PTHrP-2 indirect effects in wound healing.Results: In vivo, PTHrP-2 exerted multifunctional pro-angiogenesis, pro-firbogenesis and re-epithelization effects. In vitro, PTHrP-2 promoted proliferation and migration of endothelial and fibroblast cells, but had no effect on epithelial cells. Therefore, we tested PTHrP-2 indirect effects via exosomes. PTHrP-2 intensified intercellular communication between endothelial cells and fibroblasts and initiated endothelial-epithelial intercellular communication. PTHrP-2-HUVEC-Exos played a hub role in PTHrP-2 indirect effects in wound healing.Conclusion: These findings of this study indicated that PTHrP-2, a multifunctional factor, could promote wound healing via synergistic multicellular stimulating and exosomal activities.Graphical

1 September 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FBFan Bie
Fan Bie
KWKaiyang Wang
Kaiyang Wang
TXTao Xu
Tao Xu
JYJishan Yuan
Jishan Yuan
HDHua Ding
Hua Ding
MLMin Lan
Min Lan
Spinal cord injury (SCI) may cause long-term physical impairment and bring a substantial burden to both the individual patient and society. Existing therapeutic approaches for SCI have proven inadequate. This is mainly owing to the incomplete understanding of the cellular and molecular events post-injury. Circular RNAs (circRNAs) represent a new class of non-coding RNAs with a covalently closed annular structure that participates in regulating the transcription of certain genes and are linked to various biological processes and diseases. Mounting evidence is indicative that circRNAs are highly expressed in the spinal cord and they play key roles in multiple processes of neurological diseases. Recently, a role for circRNAs as effectors of SCI has emerged, leading to the continuity of relevant research. In this review, we presented current studies with regards to the abnormality of circRNAs mediating SCI by affecting mechanisms of autophagy, apoptosis, inflammation, and neural regeneration. Furthermore, the potential clinical value of circRNAs as therapeutic targets of SCI was also analyzed.

26 April 2025 in World Journal of Stem Cells
Verified
Journal Article
Open access
JLJing-Shun Lu
Jing-Shun Lu
CSChen-Yu Song
Chen-Yu Song
WCWen-Jing Cheng
Wen-Jing Cheng
KWKai-Yang Wang
Kai-Yang Wang
In this editorial, we comment on the recent article by Xiao et al, focusing on their investigation into whether the therapeutic efficacy of serum-free human umbilical cord mesenchymal stem cells (MSCs) differs from that of serum-containing human umbilical cord MSCs in a mouse model of knee osteoarthritis (OA). The incidence of OA has significantly increased in recent years, primarily owing to sports-related injuries or degenerative diseases. However, the regenerative capacity of articular cartilage remains limited, necessitating artificial joint replacement for patients with advanced OA to enhance the quality of life. MSCs have been widely used in the clinical treatment of OA owing to their multidirectional differentiation potential and immunomodulatory effects. The focus of this paper lies in elucidating the mechanism underlying MSC transplantation for the treatment of knee OA, while also addressing the challenges encountered in MSC therapy and outlining future directions.